Cline Scientific
Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar! Bokslutskommuniké for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2022
REG
July - December 2022
- Net sales amounted to 0 (0) SEK.
- Operating profit amounted to 237,140 (-143,519) SEK
- Profit per average number of shares after tax amounted to 0.01 (-0.01)
January - December 2022
- Net sales amounted to 0 (3,991) SEK.
- Operating profit amounted to -2,317,061 (-3,503,694) SEK
- Profit per average number of shares after tax amounted to -0.15 (-0.24)
The report is published at www.clinescientific.com/financial-reports
The company is listed on the Nasdaq First North Growth Market. Redeye AB is Cline Scientific's Certified Adviser. The information was submitted for publication via the contact person listed above, at 8.30am CET on 17 February 2023.
For more information, please contact:
Patrik Sundh, CEO
Email: patrik.sundh@clinescientific.com
Phone: +46 703-585 088
| Datum | 2023-02-17, kl 08:30 |
| Källa | Cision |